Trade Opportunity
Export Pharmaceuticals from Latvia to Slovakia under the EU-Mercosur Agreement 2026. Reduced tariffs and preferential access to a market of 780 million consumers.
📌 Why This Matters
Tariff savings of up to 4 billion euros annually benefit exporters.
📈 Growth Potential: Projected 25% increase in trade volume over the next 5 years.
🔗 Related Opportunities
📌 Why This Matters
With 780 million consumers, this market offers unprecedented opportunities.
🌍 Market Access: Direct access to 780 million consumers across 31 countries.